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ABSTRACT
Objective: Arylidene-1, 3-oxazol-5-ones represent potential antibacterial agents. In the present work, a series of 4-substituted benzylidene-2-
(phenoxymethyl) oxazol-5(4H)-ones were synthesized and screened for antibacterial activity against Gram-negative bacteria Escherichia coli. To 
explore plausible mechanisms, synthesized compounds were docked with DNA-Gyrase enzyme.
Methods: All the reactants, phenoxy acetyl chloride, acetic anhydride, sodium acetate, substituted aromatic aldehydes, and glycine were triturated in 
a mortar by mechanical stirring. The antibacterial potentiality of the compounds was screened against E. coli using the disk diffusion method and the 
activity was recorded as a zone of inhibition.
Results: Compound 2d, possessing 3, 4, 5-trimethoxy functionality on benzylidene ring exhibited the highest activity with 19 mm of the zone of 
inhibition which might be due to its higher interactions with DNA-Gyrase enzyme (ΔG-8.41 kcal/mol). Compounds 2a, 2b, and 2c exhibited moderate 
activity in the antimicrobial assay as well as in docking study indicating the positive contribution of substitution on benzylidene ring.
Conclusion: A series of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-5(4H)-ones were synthesized and evaluated for antibacterial activity. 
Compounds 2a, 2b, and 2c displayed moderate activity whereas 2d showed maximum zone of inhibition (19 mm). The good activity of these derivatives 
presumed to be due to the conformational flexibility of phenoxy methylene moiety which can be well accommodated in the target binding site.
Keywords: 4-Benzylidene-2-(phenoxymethyl) oxazol-5(4H)-ones, Molecular docking, DNA-Gyrase, Cup-plate method, Molecular properties.
INTRODUCTION
According to the recent reports, 30 new infectious diseases and existing 
infections including HIV, malaria, and tuberculosis are re-emerging 
globally at an alarming rate. Bacterial infections permeate developing 
countries, and in particular infants, children are seriously affected. 
Eravacycline and omadacycline are tetracycline antibiotics highly 
effective in bacterial skin and pneumonia infections [1,2]. The greatest 
hurdle with the existing antibacterial agents is bacterial resistance 
due to inappropriate usage of antibiotics, lack of immunity in human 
beings and fast genetic mutations in bacteria. In spite of all the available 
antibacterial agents, millions of deaths have been recorded due to 
malarial infections, tuberculosis, diarrhea, and respiratory infections. 
These data motivate researchers to develop efficacious antibacterial 
agents [3-6].
Heterocyclics such as quinoline, indoles, oxadiazoles, triazoles, thiazines, 
pyridazines, pyrazoles, and oxazoles display noticeable antibacterial 
activity against different pathological bacteria [7-11] Oxazol-5-ones 
have been extensively studied for their expansive biological activities, 
including anti-inflammatory, antidiabetic, anticancer, antimicrobial, 
antitumor, antiviral, and anti-HIV activities [11-15]. Interestingly, 1, 
3-oxazol-5-one containing compound competitively inhibited Rho-
associated coiled-coil-containing protein kinase 2, a kinase which is 
pivotal in calcium ion sensitization in vascular smooth muscle [16]. 
Diverse set of pharmacological activities of this heterocyclic moiety 
might be due to to its ability to act as hydrogen bond acceptor (HBA) 
and to form non-bonded interactions with the target site amino acids. 
Noticeably, oxazolones linked to arylidene moiety display potent 
antimicrobial activity [17-19]. The presence of arylidene linkage 
modulates/enhances the biological activity of oxazolones by altering the 
lipophilic and steric properties [20,21]. Substituted 4-benzylidene-2-
phenyloxazol-5(4H)-ones (Fig. 1) display potent antimicrobial activity 
against various Gram-negative and Gram-positive microorganisms, [18] 
and the structure-activity relationship of the studies revealed that 
the presence of methoxy group on benzylidene ring enhances the 
antibacterial activity.
Phenoxy acid moiety is found as a core scaffold in several antibacterial 
compounds [22,23]. Substituted phenoxymethyl oxazolones linked 
to arylidene moiety (Fig. 2) were synthesized by Aaglawe et al. 
In their study, it was demonstrated that substituent groups on 
benzylidene ring (4-chloro/4-bromo) exert a significant effect on 
antimicrobial activity (against Escherichia coli) [24]. In view of the 
potent antimicrobial activity of these compounds and to explore 
the influence of other functional groups (4-fluorine, 4-hydroxy, 3, 4, 
5-trimethoxy, 4-dimethyamino, 4-diethylamino) on the antimicrobial 
activity of phenoxymethyl oxazolones, it was planned to synthesize 
few 4-substituted benzylidene-2-(phenoxymethyl) oxazol-5(4H)-ones. 
The synthesized compounds were evaluated for their antimicrobial 
potentiality using E. coli.
Mechano heterocyclic chemistry involves applying mechanical energy 
such as grinding (grindstone technique) which accelerates the rate of 
reaction. The multicomponent approach provides simple procedures to 
synthesize complex structures [25-27].
METHODS
“Thermonik Precision Melting point cum boiling point apparatus, 
model C-PMB-2 was used for melting point determination and 
values are uncorrected. Phenoxy acetic acid and acetic anhydride 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i5.31390
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Fig. 1: 4-Substituted benzylidene-2-phenyloxazol-5(4H)-ones
Fig. 2: 4-Substituted benzylidene-2-(phenoxymethyl)  
oxazol-5(4H)-ones
were purchased from Sigma-Aldrich chemicals, and other chemicals 
were from Merck and HiMedia. Microorganisms were obtained from 
the Faculty of Microbiology, Sri Padmavati Mahila Visvavidyalayam, 
Tirupati, India. Thin-layer chromatography (TLC) was used to observe 
the reaction and to check the purity of synthesized compounds. Iodine 
chamber was used to develop spots. Infrared (IR) spectral studies 
were performed using KBr disks on Perkin Elmer Spectrum BX-I IR 
spectrophotometer (cm−1). The proton nuclear magnetic resonance 
(1H NMR) spectra were obtained by dissolving the samples in CDCl3 
on JOEL-400 instrument. Mass (m/z) spectra were obtained using 
LCMS-8030 Mass Spectrometer (mass selective detector). The title 
compounds (2a-2f) were recrystallized twice from alcohol and water 
mixture.
General procedure for the synthesis of 4-substituted benzylidene-
2-(phenoxymethyl) oxazol-5(4H)-one
Synthesis of 4-benzylidene-2-(phenoxymethyl) oxazol-5(4H)-one
Step 1: Synthesis of phenoxy acid chloride (1)
Phenoxy acetic acid (0.01 mol) and thionyl chloride (0.01 mol) were 
mixed properly and refluxed for 2 h. Excess of thionyl chloride was 
removed by applying vacuum distillation [28].
Step 2: Synthesis of 4-benzylidene-2-(phenoxymethyl) oxazol-5(4H)-
one
Equimolar amounts of glycine, 4-fluorobenzaldehyde, phenoxy acetyl 
chloride, fused sodium acetate, and few drops of acetic anhydride 
were triturated in a porcelain mortar and pestle for 15–30 min [27]. 
Completion of the reaction was monitored by TLC; the resultant solid 
was washed with cold water and recrystallized from ethanol and water 
mixture to obtain crude compound (2a).
Similarly, other 4-substituted benzylidene-2-(phenoxymethyl) oxazol-
5(4H)-ones (2b-2f) were synthesized following a similar procedure 
where substituted benzaldehydes were used in place of 4-fluoro 
benzaldehyde (Fig. 3).
Antimicrobial activity
The antibacterial activity was tested against E. coli by the cup-plate 
method.
Preparation of agar media
Agar medium was prepared by mixing meat extract (0.9 g), peptone 
(1.5 g), and agar (5 g) in 100 ml of distilled water. The antibiotic amikacin 
was used to compare the activities of the test compounds against 
various bacteria. Amikacin activity was screened by preparing specific 
media which includes agar (2 g), peptone (0.6 g), yeast extract (0.3 g), 
and beef extract (0.15 g) in 100 ml distilled water.
Preparation of test compounds
Stock solutions (2a-f) were prepared by dissolving 5 mg/mL of the 
title compounds in dimethyl sulfoxide (DMSO), and from these, 50 μL 
and 100 μL test solutions were prepared. DMSO was used as negative 
control. Tests, as well as negative control, were added with the help of 
sterile pipettes.
Procedure
A small quantity of microbial suspension was added to the agar media 
(45–50°C), and agar media were immediately transferred to sterile Petri 
plates. When media were settled, around 4 mm plugs of the media were 
removed using a sterile corn borer into each Petri plate. Test solutions 
of exact volume were added to the holes and incubated for 24 h. The 
zone of inhibition was measured in millimeters after 24 h. Each test 
was conducted as triplicates and the average zone of inhibition was 
considered.
Prediction of molecular and absorption, distribution, metabolism, 
and excretion (ADME) descriptors
Prediction of molecular, pharmacokinetic properties, and toxicity 
is inevitable in the current drug development process. Log P 
(lipophilicity), HBD (number of hydrogen bond donors), HBA, 
topological polar surface area as well as the bioactivity scores, i.e., 
affinity of the compounds for various targets such as G-protein coupled 
receptor, ion channel, kinase, nuclear receptor, protease, and enzyme 
were predicted using online tool (http://www. molinspiration. com/
cgi-bin/properties). ADME properties of the title compounds were 
predicted using the preADMET online server (http://preadmet.bmdrc.
org/). Various ADME properties including CaCo2 cell permeability, 
human intestinal absorption, plasma protein binding, blood-brain 
barrier penetration, skin permeability, and Maden Darby canine 
kidney cell permeability were predicted.
Swiss dock studies
Molecular docking studies were performed by Swiss Dock, a user-
friendly tool. The protein and ligand structures can be directly 
submitted for docking and results of the docking studies can be viewed 
by chimera [29,30].
Protein
The crystal structure of DNA-Gyrase subunit B was retrieved from the 
protein data bank (PDB entry: 1KZN). Chain A was selected for the 
docking study which includes 205 amino acids. Ligand structures were 
submitted in mol.2 form and the results were viewed in chimera.
Ligands
Ligand structures (Figs. 4 and 5) were submitted in mol.2 forms.
RESULTS AND DISCUSSION
Chemistry
A series of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-
5(4H)-ones were synthesized by triturating phenoxy acetyl chloride, 
sodium acetate, acetic anhydride, glycine, and substituted benzaldehyde 
in a mortar (mechanochemical grinding method). Compounds were 
obtained in good yields (60–78%). Title compounds were obtained 
within 15–30 min. The synthesized compounds were purified by 
recrystallization using an aqueous-alcoholic mixture. The physical 
data of the compounds are given in Table 1. The structures of the final 
compounds were characterized by spectral data including UV, IR,1H 
NMR, and mass spectral analysis.
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Fig. 3: Scheme for the synthesis of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-5(4H)-ones (2a-2f)
Fig. 5: 4-Substituted benzylidene-2-phenyloxazol-5(4H)-ones 
(1-6)
Fig. 4: 4-Substituted benzylidene-2-(phenoxymethyl) oxazol-
5(4H)-ones (2a-2f)
General structure of the synthesized compounds
Physicochemical data of compounds 2a-2f
2a: 4-(4-fluorobenzylidene)-2-(phenoxymethyl) oxazol-5(4H)-one
Fourier-transform IR (FTIR) (KBr) cm−1: 2958.78 (C-H aromatic str), 
2855.12 (C-H aliphatic stretch), 1735.78 (C=O str of lactone ring), 1665.20 
(C=C str), 870.25 (C-H aromatic bend).1H NMR (CDCl3): δ4.08(s, 2H, -OCH2-), 
7.01–7.85 (m, 10H, Ar-H&=CH-) NMR (CDCl3) MS (m/z): 298.28[M+1]+ 
Elemental Analysis: C, 68.76; H, 4.06; F, 6.38; N, 4.74; O, 16.14.
2b: 4-(4-nitrobenzylidene)-2-(phenoxymethyl) oxazol-5(4H)-one
FTIR (KBr) cm−1: 2958.35 (C-H aromatic str), 2918.69 (C-H aliphatic 
str), 1760.11 (C=O str of lactone ring), 1671.40 (C=C str), 831.43 
(C-H aromatic bend).1H NMR (CDCl3): δ4.12(s, 2H, -OCH2-), 6.75–7.48 
(m, 10H, Ar-H&=CH-) MS (m/z): 338.3 [M]+.
2c: 4-(4-hydroxybenzylidene)-2-(phenoxymethyl) oxazol-5(4H)-one
FTIR (KBr) cm−1: 2998.14 (C-H aromatic str), 2875.19 (C-H aliphatic 
str), 1724.35(C=O str of lactone ring), 1665.32 (C=C str), 890.01 
IR spectra of the compounds showed bands at 2950–2900 due to 
C-H aromatic; 2850–2800 due to C-H aliphatic; 1760–1720 cm−1 
due to C=O in the lactone ring; and 1650–1600 cm−1 due to C=C.1H 
NMR data clearly indicated the presence of phenoxy methylene 
protons at around 4.0–4.5 ppm and aromatic protons were observed 
around 6.42–7.89 ppm. Mass spectrum of the compounds showed 
characteristic peaks (M+).
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(C-H aromatic bend).1H NMR (CDCl3): δ 54.12 (s, 2H, -OCH2-), 0.01 
(s, 3H, OH) 6.42–7.56 (m, 10H, Ar-H&=CH-) MS (m/z): 295.6 [M]+.
2d: 2-(phenoxymethyl)-4-(3, 4, 5-trimethoxybenzylidene) oxazol-
5(4H)-one
FTIR (KBr) cm−1: 2958.47 (C-H aromatic str), 2904.24 (C-H 
aliphatic str), 1750.87(C=O str of lactone ring), 1668.57 (C=C str), 
890.68 (C-H aromatic bend).1H NMR (CDCl3): δ 3.09 (s, 3H, OCH3) 
3.11(s, 6H, (OCH3)2, 4.12 (s, 2H, -OCH2-), 6.91–7.88 (m, 8H, Ar-H&=CH-) 
MASS (m/z): 370.14 [M+1]+.
2e: 4-(4-(dimethylamino) benzylidene)-2-(phenoxymethyl) oxazol-
5(4H)-one
FTIR (KBr) cm−1: 3058.24 (C-H aromatic str), 2904.50 (C-H aliphatic 
str), 1741.28 (C=O str of lactone ring), 1656.32 (C=C stretch), 865.29 
(C-H aromatic bend).).1H NMR (CDCl3): δ 3.89 (s, 6H, N (CH3)2, 4.09 
(s, 2H, -OCH2-), 6.93–7.89 (m, 10H, Ar-H&=CH-) MS (m/z): 322.4 [M]+.
2f: 4-(4-(diethylamino) benzylidene)-2-(phenoxymethyl) oxazol-
5(4H)-one
FTIR (KBr) cm−1: 2989.68 (C-H aromatic str), 2897.08 (C-H aliphatic 
str), 1724.53 (C=O stretch of lactone ring), 1663.85 (C=C str), 874.15 
(C-H aromatic bend).1H NMR (CDCl3): δ 1.68–1.73[t, 6H, (CH3)2] 3.42 
(q, 4H, NCH2 (CH3)2, 4.12 (s, 2H, -OCH2-), 7.01–7.88 (m, 10H, Ar-H&=CH-) 
MS (m/z): 350.5[M]+.
Antibacterial activity
The title compounds (2a-2f) were tested for their antibacterial activity 
against E. coli. Compounds were dissolved in DMSO and used at a 
concentration of 50 µg and 100 µg/ml. The activity was recorded as a 
zone of inhibition after the incubation period of 24 h at 37°C.
Table 1: Physical data of the title compounds
S. No. Compounds number R Color M.F M.W M.P (°C) UV
1 2a 4-F Cream C17H12FNO3 297.28 126–128 225 and 229.2
2 2b 4-NO2 Orange C17H12N3O5 338.29 136–138 302 and 302.8
3 2c 4-OH Orange C17H13NO4 295.29 122–124 345
4 2d 3,4,5-(OCH3) 3 Cream C20H19NO6 369.37 140–142 238 and 263.5
5 2e 4-N (CH3) 2 Cream C19H18N2O3 322.36 151–153 296 and 229.7
6 2f 4-N (C2H5) 2 Green C21H22N2O3 350.41 155–157 294 and 294.8
Table 2: Antibacterial activity (zone of inhibition)
S. No. Compound R Concentration (μg/ml) Zone of inhibition (mm)
2 2a 4-F 50 12±0.2
100 14±0.4
4 2b 4-NO2 50 8±0.2
100 9±0.5
5 2c 4-OH 50 8±0.2
100 8±0.4
6 2d 3,4,5-(OCH3)3 50 16±0.6
100 19±0.8
7 2e 4-N (CH3)2 50 5±0.2
100 6±0.2
8 2f 4-N (C2H5)2 50 5±0.3
100 7±0.5
Amikacin -- -- 28±1.2















2a 4-F −0.69 −1.02 −0.51 −0.51 −0.75 −0.43
2b 4-NO2 −0.78 −0.99 −0.63 −0.58 −0.78 −0.50
2c 4-OH −0.40 −0.61 −0.10 −0.40 −0.42 −0.12
2d 3,4,5-(OCH3)3 −0.61 −0.90 −0.45 −0.52 −0.64 −0.38
2e 4-N (CH3)2 −0.62 −0.96 −0.45 −0.46 −0.66 −0.40
2f 4-N (C2H5)2 −0.55 −0.90 −0.45 −0.44 −0.62 −0.42
GPCR: G-protein coupled receptor
Table 3: Molecular properties of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-5 (4H)-ones
Compound number R miLogP TPSA MW nON nOH
NH
Nviol Nrotb MV
2a 4-F 3.45 52.34 297.29 4 0 0 4 253.97
2b 4-NO2 3.24 98.16 324.29 7 0 0 5 272.38
2c 4-OH 2.69 72.56 259.29 5 1 0 4 257.06
2d 3,4,5-(OCH3)3 2.92 80.04 369.37 7 0 0 7 325.68
2e 4-N (CH3)2 3.39 55.58 322.36 5 0 0 5 294.95
2f 4-N (C2H5)2 4.14 55.58 350.42 5 0 0 7 328.55
miLogP - (Lipophilicity); TPSA: Topological surface area, MW: Molecular weight, ON - Sum of hydrogen bond receptors, OHNH: Sum of hydrogen bond donors, Nviol: 
Number of Violations, Nrotb: Number of rotatable bonds, MV: Molecular volume
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The data showed 3, 4, 5- trimethoxy derivative (2d) as potent derivative 
among all the compounds which showed the zone of inhibition of 
19 mm at 100 μg/ml and 16 mm at 50 μg/ml, respectively (Fig. 6). In 
the case of 4-substituted benzylidene-2-(phenyl) oxazol-5(4H)-ones, it 
was observed that methoxy substitution on benzylidene is favorable for 
antibacterial activity against Gram-negative as well as Gram-positive 
organisms [18]. Similarly, in the present study, methoxy functionality 
is found to be favorable. However, the potency of 2d is less than that 
of amikacin, a standard drug which exhibited 28 mm of the zone of 
inhibition. The fluoro derivative (2a) also showed significant inhibition 
with the zone of inhibition of 14 mm at 100 μg/ml concentration and 
12 mm at 50 μg/ml. Introduction of fluorine enhances the lipophilicity 
of the molecule and also creates a dipole charge between carbon 
and fluorine. Lipophilicity and dipole charges increase the ability of 
a compound to form various interactions at the target binding site. 
4-Hydroxy, 4-dimethylamino and 4-diethyl amino derivatives (2c, 2e, 
and 2f) were unable to exert any significant activity against E. coli 
(Table 2). The poor activity of 2c, 2e, and 2f suggested that electron 
releasing substituent groups are not significantly contributing to the 
activity.
These observations indicated that 4-fluoro and 3, 4, 5-trimethoxy 
substitution on benzylidene ring significantly favor antibacterial activity 
against E. coli. In summary, it can be suggested that the introduction 
of phenoxy methylene linker in the oxazoles-5-one structure is a good 
strategy to develop antibacterial agents.
Prediction of molecular properties
All the compounds were predicted to have good oral bioavailability as 
their molecular weight is <500 (297–369), hydrogen bond donors are 
<5 (0), HBA are <10 (4–7), and no of rotatable bonds are <10 (4–7) 
(Tables 3 and 4). Pharmacokinetic properties prediction showed that 
their absorption in the gastrointestinal tract will be good (Table 5).
Lipinski rule: miLog p≤5, MW ≤500, HBA ≤10 and HBD ≤5.
Molecular docking studies
Fluoroquinolones and coumarin derivatives are potent antimicrobial 
agents which act by DNA Gyrase inhibition. DNA Gyrase with its 
subunits (2 Gyr A and 2 Gyr B) introduces negative supercoils in 
DNA and effectively inhibits initiation step of DNA synthesis [31]. 
Interestingly, several potent inhibitors such as novobiocin, clorobiocin, 
cyclothialidine, and 5ʹ-adenylyl-β,γ-imidodiphosphate (ATP analog) 
were found to interact with Asp-73, crucial amino acid present in the 
ATP binding domain of DNA Gyrase [32]. Basarab et al. synthesized 
spiropyrimidinetriones with a benzisoxazole heterocyclic scaffold and 
reported that these derivatives possess potent DNA Gyrase inhibitory 
activity [33]. Literature findings revealed that various oxazolones 
derivatives exhibit potent antimicrobial activity against Gram-
negative and Gram-positive organisms. Previously, molecular docking 
studies were performed for a series of 4-benzylidene-2-(4-hydroxy-3-
methoxystyryl) oxazol-5(4H)-ones and the binding poses revealed that 
these molecules were able to interact with Asp-73 and Arg-176 amino 
acids [34].
Molecular docking studies were performed to explore binding affinities 
of synthesized compounds with the target enzyme.
4-Substituted benzylidene-2-(phenoxymethyl) oxazol-5(4H)-ones
In the series of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-
5(4H)-ones, 3, 4, 5-trimethoxy derivative, 2d, exhibited good interaction 
Table 5: ADME parameters of 4-substituted benzylidene-2-(phenoxymethyl) oxazol-5 (4H)-ones
Compound 
number
R Absorption PPB BBB SKIN MDCK
HIA CaCo2
2a 4-F 97.83 35.37 92.73 1.77 -3.11 21.32
2b 4-NO2 95.50 14.75 92.36 0.01 -3.00 237.62
2c 4-OH 96.41 21.80 92.76 0.25 -3.00 29.26
2d 3,4,5-(OCH3)3 96.63 51.93 84.67 0.03 -3.39 142.40
2e 4-N (CH3)2 95.87 54.71 93.34 0.69 -3.06 158.75
2f 4-N (C2H5)2 96.06 56.19 93.57 0.55 -2.79 105.67
CaCo2: CaCo2 cell permeability, HIA: Human intestinal absorption, PPB: Plasma protein binding, BBB: Blood-brain barrier penetration, SKIN: Skin permeability, MDCK: 
Maden Darby canine kidney cell permeability. ADME: Absorption, distribution, metabolism, and excretion
Table 6: Docking results for 4-Substituted benzylidene-2-(phenoxymethyl) oxazol-5 (4H)-ones
S. No. R Energy (∆G) Full fitness Interacting amino acids Bond distance(Aº)
2a 4-F −7.82 −1291.94 Thr-165 H-Lig O
Gly-77 NH- Lig O
2.41
2.34
2b 4-NO2 −8.05 −1270.80 Asn-46 H-Lig O 2.62




2d 3,4,5- OCH3 −8.41 −1265.74 Arg-76 H-Lig O 2.51
2e 4-N (CH3)2 −7.94 −1293.08 Asn-46 H-Lig O 2.87
2f 4-N (C2H5)2 −7.80 −1286.35 Asn-46 H-Lig O 2.25







Fig. 6: (a and b) Zone of inhibition of 2a and 2d
a b
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with DNA-Gyrase enzyme (ΔG of −8.41 kcal/mol). Abolhasani et al. 
mentioned the importance of methoxy functionality and substitution 
pattern of methoxy groups at the target binding site [35]. Moderate 
binding interactions were observed for all the other derivatives 
indicating that their presence enhances the affinity of the molecule 
for the target binding site. Ciprofloxacin showed good interaction with 
−7.91 kcal/mol of Gibbs free energy (Table 6).
To compare the influence of oxymethylene linker, SwissDock studies 
were performed using a set of 4-substituted benzylidene-2-(phenyl) 
oxazol-5(4H)-ones (1-6) with the same substitution as of 4-substituted 
benzylidene-2-(phenyl) oxazol-5(4H)-ones (2a-2f).
4-Substituted benzylidene-2-(phenyl) oxazol-5(4H)-ones
Results showed that Gibbs free energy (ΔG) values for 4-substituted 
benzylidene-2-(phenyl) oxazol-5(4H)-ones were found to be 
in the range of −7.40 kcal/mol to –8.11 kcal/mol whereas for 
4-substituted benzylidene-2-(phenoxymethyl) oxazol-5(4H)-
ones, the values were found to be from −7.82 kcal/mol to −8.41 
kcal/mol. Replacement of phenyl ring with conformationally 
flexible phenoxy methylene moiety augments binding interactions 
with the target enzyme. Results showed that 3, 4, 5-trimethoxy 
derivative (4) demonstrated binding affinity of −8.11 kcal/mol and 
other derivatives also showed good interactions with the active 
site (Table 7).
There is no similarity in the binding poses of ciprofloxacin and the 
synthesized compounds except in the case of 2a; ciprofloxacin formed 
three hydrogen bonds with Asp-73, Gly-77, and Thr-165 (Fig. 7) and 
2a similarly found to interact with Gly-77 and Thr-165. All the other 
compounds 2b-2f were situated near Asn-46 and formed hydrogen 
bonding with this amino acid. Compound 2d formed hydrogen bonding 
interactions with Arg-76 (Figs. 7 and 8). Binding orientations of 
4-substituted benzylidene-2-(phenyl) oxazol-5(4H)-ones were almost 
identical to that of 4-substituted benzylidene-2-(phenoxymethyl) 
oxazol-5(4H)-ones where 4-fluoro substituted derivative showed 
hydrogen bonding with Gly-77 and Thr-165 and other derivatives were 
bonded with Asn-46.
The correlation was observed between molecular docking studies 
and in vitro antibacterial activity in case of active compound 2d, 
which showed high activity against E. coli (zone of inhibition 19 mm 
at 100 μg/ml) and good interactions with DNA-Gyrase enzyme (ΔG 
of −8.41 kcal/mol).
Table 7: Docking results for 4-substituted benzylidene-2-(phenyl) oxazol-5 (4H)-ones
S. No. R Energy (∆G) Full fitness Interacting amino acids Bond distance(Aº)








3 4-OH −7.68 −1301.43 Asp-73 O-Lig H 1.88
4 3,4,5- OCH3 −8.11 −1264.53 Asn-46 H-Lig O 2.78
5 4-N (CH3) 2 −7.86 −1212.35 Asn-46 H-Lig O 2.65
6 4-N (C2H5) 2 −7.60 −1292.19 Asn-46 H-Lig O 2.66
Fig. 7 (a) Compound 2d interaction with amino acids, (b) hydrophobic mode
a b
Fig. 8: (a) Binding mode of ciprofloxacin in the active site of DNA gyrase, (b) hydrophobic mode
a b
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CONCLUSION
A series of 4-substituted benzylidene-2-phenyloxazol-5(4H)-ones 
were synthesized in good yields by applying the mechanochemical 
stirring approach. It was interesting to observe that the insertion of 
oxymethylene linker between 1, 3-oxazol-5-one scaffold and phenyl 
ring; a simple structural modification increased the potentiality 
of compounds. 4-Fluoro substitution (2a) and 3, 4, 5-trimethoxy 
substitution (2d) on benzylidene ring significantly enhanced the 
antibacterial activity against E. coli. High activity of active compounds 
might be due to their good binding affinity toward the target enzyme 
DNA gyrase. The data regarding molecular and ADME properties 
indicate druggability of the title compounds.
ACKNOWLEDGMENTS
The authors are very thankful to DST-CURIE (Consolidation of University 
Research for Innovation and Excellence in Women Universities) 
SPMVV, Tirupati, for providing FTIR spectral data of the synthesized 
compounds.
AUTHORS’ CONTRIBUTIONS
All authors have made considerable contributions to the work reported 
in the manuscript. Maneesha M, Ome Shanthi T, and Satya varalakshmi 
D synthesized and screened the compounds for antibacterial activity. 
Manjusha RK performed molecular docking study using SwissDock and 
other in silico studies mentioned in the manuscript. Shaheen Begum 
and Arifa Begum prepared the manuscript and Bharathi K supervised 
and reviewed the work.
CONFLICTS OF INTEREST
The authors confirm that this article content has no conflicts of interest.
REFERENCES
1. Mukherjee S. Emerging infectious diseases: Epidemiological 
perspective. Indian J Dermatol 2017;62:459-67.
2. Noel GJ, Draper MP, Hait H, Tanaka SK, Arbeit RD. A randomized, 
evaluator-blind, phase 2 study comparing the safety and efficacy of 
omadacycline to those of linezolid for treatment of complicated skin and 
skin structure infections. Antimicrob Agents Chemother 2012;56:5650-4.
3. Lin J, Nishino K, Roberts MC, Tolmasky M, Aminov RI, Zhang L, et al. 
Mechanisms of antibiotic resistance. Front Microbiol 2015;6:1-3.
4. Brown ED, Wright GD. Antibacterial drug discovery in the resistance 
era. Nature 2016;529:336-43.
5. Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AP, Nautiyal AR, 
et al. Antimicrobial resistance and the alternative resources with special 
emphasis on plant-based antimicrobials-a review. Plants 2017;6:1-11.
6. Haque M. Antimicrobial use, prescribing, and resistance in selected ten 
selected developing countries: A brief overview. Asian J Pharm Clin 
Res 2017;10:37-45.
7. El-Gamal KM, Sherbiny FF, El-Morsi AM, Abu-El-Khair HE, Eissa IH, 
El-Sebaei MM. Design, synthesis and antimicrobial evaluation of some 
novel quinoline derivatives. Pharm Pharmacol Int J 2015;2:165-77.
8.	 Onkol	 T,	 Doğruer	 DS,	 Uzun	 L,	 Adak	 S,	 Ozkan	 S,	 Sahin	 MF,	
et al. Synthesis and antimicrobial activity of new 1,2,4-triazole and 
1,3,4-thiadiazole derivatives. J Enzyme Inhib Med Chem 2008;23: 
277-84.
9. El-Salam NM, Mostafa MS, Ahmed GA, Alothman OY. Synthesis and 
antimicrobial activities of some new heterocyclic compounds based on 
6-chloropyridazine-3 (2H) -thione. J Chem 2013;13:1-8.
10. Sharma R. Review: Antimicrobial agents based on nitrogen and sulfur 
containing heterocycles. Asian J Pharm Clin Res 2017;10:47-9.
11. Rajitha G, Prasad KV, Bharathi K. Synthesis and biological evaluation 
of 3-amino pyrazolones. Asian J Chem 2011;23:684-6.
12. Bala S, Saini M, Sunil K. Methods for synthesis of oxazolones: 
A review. Int J Chemtech Res 2011;3:1102-18.
13. Sharada LN, Aparna Y, Saba M, Sunitha SN, Viveka L. A review on 
reactions and applications of oxazolones. Int J Sci Res 2015;5:1-9.
14. El-Mekabaty A. Erlenmeyer azlactones: Synthesis, reactions and 
biological activity. Int J Mod Org Chem 2013;2:40-66.
15. Mariappan G, Saha BP, Datta S, Kumar D, Haldar PK. Design, 
synthesis and antidiabetic evaluation of oxazolone derivatives. J Chem 
Sci 2011;123:335-41.
16. Al-Ghabkari A, Deng JT, McDonald PC, Dedhar S, Alshehri M, 
Walsh MP, et al. A novel inhibitory effect of oxazol-5-one compounds 
on ROCKII signaling in human coronary artery vascular smooth muscle 
cells. Sci Rep 2016;6:32118.
17. Jat LR, Mishra R, Pathak D. Synthesis and anticancer activity of 
4-benzylidene-2- phenyloxazol-5(4h)-one derivatives. Int J Pharm 
Pharm Sci 2012;4:378-80.
18. Saravanan VS, Selvan PS, Gopal N, De B, Gupta JK. Synthesis and 
antibacterial activity of some 4-substituted-2-phenyl oxazol-5(4H)-one 
derivatives. Asian J Chem 2006;18:2511-4.
19. Bayoumi WA, Shaymaa HA, Mohamed ES. Synthesis and evaluation of 
new 2-iminothiazolidin-4-one and thiazolidin-2, 4-dione derivatives as 
antimicrobial and anti-inflammatory agents. Open Chem J 2014;1:33-8.
20. Ottana R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, et al. 
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel 
anti-inflammatory agents. Bioorg Med Chem 2005;13:134243-52.
21. Vicini P, Zani F, Cozzini P, Doytchinova I. Hydrazones of 
1,2-benzisothiazole hydrazides: Synthesis, antimicrobial activity and 
QSAR investigations. Eur J Med Chem 2002;37:553-64.
22. Amjid I, Hamid LS, Ashraf CM, Ahmad M, Weaver GW. Synthesis, 
characterization and antibacterial activity of azomethine derivatives 
derived from 2-formylphenoxyacetic acid. Molecules 2007;12:245-54.
23. Pattan SR, Hullolikar RL, Pattan JS, Kapadnis BP, Dighe NS, 
Dengale SS. Synthesis and evaluation of some new pyrazolo phenoxy 
acetic acid derivatives for their antitubercular activity. J Pharm Sci Res 
2009;1:63-8.
24. Aaglawe MJ, Dhule SS, Bahekar SS, Wakte PS, Shinde DB. Synthesis 
and antibacterial activity of some oxazolone derivatives. J Korean 
Chem Soc 2003;47:133-6.
25. Varma RS. Greener chemical syntheses using mechanochemical 
mixing or microwave and ultrasound irradiation. Green Chem Lett Rev 
2007;1:37-45.
26. Leonardi M, Villacampa M, Menéndez JC. Multicomponent 
mechanochemical synthesis. Chem Sci 2018;9:2042-64.
27. El-Sayed AA, Hemdan MM, Fahmy AF. Multicomponent synthesis 
of 4-arylidene-2-phenyl-5(4H)-oxazolones (azlactones) using a 
mechanochemical approach. Chem Cent J 2016;10:1-7.
28. Rajitha G, Prasad KV, Bharathi K. Synthesis and evaluation of 
substituted cinnamoyl alanines for antiinflammatory, analgesic and 
antioxidant activities. Asian J Chem 2010;22:1197-04.
29. Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small 
molecule docking web service based on EADock DSS. Nucleic Acids 
Res 2011;39:W270-7.
30. Soujanya M, Rajitha G. Microwave assisted synthesis, characterization, 
molecular docking and antimicrobial evaluation of 4-nitrocinnamide 
analogues. Int J Pharm Sci Res 2017;8:3786-94.
31. Walker SS, Labroli M, Painter RE, Wiltsie J, Sherborne B, Murgolo N, 
et al. Antibacterial small molecules targeting the conserved TOPRIM 
domain of DNA gyrase. PLoS One 2017;12:e0180965.
32. Mayer C, Janin YL. Non-quinolone inhibitors of bacterial Type IIA 
topoisomerases: A feat of bioisosterism. Chem Rev 2014;114:2313-42.
33. Basarab GS, Brassil P, Doig P, Galullo V, Haimes HB, Kern G. Novel 
DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole 
scaffold: SAR and in vivo characterization. J Med Chem 2014;57: 
9078-95.
34. Manjusha RK, Begum A, Swapna B, Begum S, Bharathi K, 
Sujatha D. Molecular docking studies of 4-benzylidene-2-(4-
hydroxy-3- methoxystyryl) oxazol-5(4H)-ones; Interactions with Arg-
136 and Asp-73 of DNA gyrase. J Glob Trends Pharm Sci 2018;9: 
5172-80.
35. Abolhasani H, Zarghi A, Hamzeh-Mivehroud M, Alizadeh AA, 
Mojarrad SD. In-silico investigation of tubulin binding modes of a 
series of novel antiproliferative spiroisoxazoline compounds using 
docking studies. Iran J Pharm Res 2015;14:141-7.
